KMT2A and metastatic prostate carcinoma: The fusion of ARHGEF12 with histone-lysine N-methyltransferase 2A gene (KMT2A) has been reported in leukemic patients 22, 23, and ARHGEF12 mutations have also been found in metastatic prostate cancer 71.